Organovo Holdings Inc (ONVO)
0.40
+0.05
(+14.32%)
USD |
NASDAQ |
Nov 22, 16:00
0.395
0.00 (0.00%)
After-Hours: 20:00
Organovo Holdings Total Liabilities (Quarterly): 3.074M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 3.074M |
June 30, 2024 | 2.808M |
March 31, 2024 | 2.748M |
December 31, 2023 | 2.699M |
September 30, 2023 | 2.705M |
June 30, 2023 | 2.98M |
March 31, 2023 | 4.984M |
December 31, 2022 | 2.79M |
September 30, 2022 | 2.904M |
June 30, 2022 | 2.892M |
March 31, 2022 | 3.087M |
December 31, 2021 | 3.802M |
September 30, 2021 | 1.675M |
June 30, 2021 | 0.964M |
March 31, 2021 | 0.721M |
December 31, 2020 | 0.829M |
September 30, 2020 | 0.657M |
June 30, 2020 | 0.835M |
March 31, 2020 | 1.81M |
December 31, 2019 | 2.358M |
September 30, 2019 | 6.698M |
June 30, 2019 | 7.312M |
March 31, 2019 | 4.325M |
December 31, 2018 | 4.01M |
September 30, 2018 | 3.755M |
Date | Value |
---|---|
June 30, 2018 | 3.736M |
March 31, 2018 | 5.241M |
December 31, 2017 | 4.953M |
September 30, 2017 | 4.853M |
June 30, 2017 | 4.443M |
March 31, 2017 | 6.818M |
December 31, 2016 | 5.227M |
September 30, 2016 | 5.049M |
June 30, 2016 | 4.004M |
March 31, 2016 | 5.395M |
December 31, 2015 | 5.497M |
September 30, 2015 | 5.525M |
June 30, 2015 | 5.244M |
March 31, 2015 | 4.793M |
December 31, 2014 | 3.76M |
September 30, 2014 | 3.114M |
June 30, 2014 | 3.09M |
March 31, 2014 | 1.902M |
December 31, 2013 | 2.914M |
September 30, 2013 | 2.956M |
June 30, 2013 | 7.60M |
December 31, 2012 | 22.05M |
September 30, 2012 | 36.47M |
June 30, 2012 | 81.47M |
March 31, 2012 | 48.63M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.657M
Minimum
Sep 2020
4.984M
Maximum
Mar 2023
2.366M
Average
2.726M
Median
Total Liabilities (Quarterly) Benchmarks
CEL-SCI Corp | 15.60M |
AIM ImmunoTech Inc | 10.68M |
IGC Pharma Inc | 2.992M |
NovaBay Pharmaceuticals Inc | 2.805M |
Protalix BioTherapeutics Inc | 29.13M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.754M |
Shareholders Equity (Quarterly) | 3.68M |
Current Ratio | 1.981 |